Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

PURPOSE: Anaplastic thyroid carcinoma (ATC) is one of the most lethal human cancers with a median survival of 6 months. The inhibition of epidermal growth factor receptor (EGFR) alone, or with vascular endothelial growth factor receptor2 (VEGFR2), represents an attractive approach for treatment of A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gule, Maria K., Chen, Yunyun, Sano, Daisuke, Frederick, Mitchell J., Zhou, Ge, Zhao, Mei, Milas, Zvonimir L., Galer, Chad E., Henderson, Ying C., Jasser, Samar A., Schwartz, David L., Bankson, James A., Myers, Jeffrey N., Lai, Stephen Y.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3079006/
https://ncbi.nlm.nih.gov/pubmed/21220477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2762
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados